8. AngioDynamics Inc. (NASDAQ:ANGO)
Fiscal first-quarter 2027 revenue increased 6.9%, with Med Tech sales growing 13.2%. However, the company used approximately $15.3 million in operating cash, creating a useful question about whether growth can translate into sustainable cash generation.
READ THIS: AngioDynamics (ANGO) Grows Faster but Can the Cash Catch Up?
